| Literature DB >> 6189504 |
M J Peckham, A Barrett, K H Liew, A Horwich, B Robinson, H J Dobbs, T J McElwain, W F Hendry.
Abstract
Between July 1979 and December 1981, 43 patients with metastatic germ-cell tumours (36 testicular non-seminomas and 7 testicular seminomas) were treated with 2-6 cycles of bleomycin, etoposide and cis-platin (BEP). Forty (93%) are alive, 37 (86%) with no evidence of disease. Of 36 men with testicular non-seminoma 30 (83.3%) are alive and disease-free at 8-38 months (median 17.0 months). In the latter group 25/28 (89.3%) who had had no prior irradiation are alive and disease-free. Fourteen non-seminoma patients had small volume metastases and 13 are in complete remission, as are 12/14 patients with bulky disease. All 7 patients with advanced seminoma are alive and disease-free. It is concluded that BEP is a well tolerated and effective first line treatment for patients with metastatic germ-cell tumours.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6189504 PMCID: PMC2011384 DOI: 10.1038/bjc.1983.99
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640